Shares of BioPharma Credit (LON:BPCR - Get Free Report) traded up 0.7% on Monday . The company traded as high as GBX 0.88 ($0.01) and last traded at GBX 0.88 ($0.01). 1,612,236 shares changed hands during trading, an increase of 85% from the average session volume of 870,677 shares. The stock had previously closed at GBX 0.87 ($0.01).
BioPharma Credit Price Performance
The business has a 50-day moving average of GBX 0.88 and a two-hundred day moving average of GBX 0.87. The company has a market cap of £1.05 billion, a P/E ratio of 10.03 and a beta of 0.22.
BioPharma Credit Company Profile
(
Get Free Report)
BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in London, the United Kingdom.
Read More
Before you consider BioPharma Credit, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BioPharma Credit wasn't on the list.
While BioPharma Credit currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
